Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it ...

Leukaemia & Lymphoma NI (LLNI) marked its 60th anniversary in style with a Black Tie and Diamonds Gala Ball, celebrating six ...

For patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen ...

Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

An event aimed at spreading light and hope for patients and families dealing with the impacts of blood cancer returns Thursday.

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best ...

The Leukemia and Lymphoma Society is once again hosting Light The Night to bring light to the darkness of cancer. Last year, ...